Biotest Balance Sheet Health
Financial Health criteria checks 3/6
Biotest has a total shareholder equity of €527.9M and total debt of €693.2M, which brings its debt-to-equity ratio to 131.3%. Its total assets and total liabilities are €1.4B and €918.9M respectively. Biotest's EBIT is €178.6M making its interest coverage ratio 5. It has cash and short-term investments of €84.7M.
Key information
131.3%
Debt to equity ratio
€693.20m
Debt
| Interest coverage ratio | 5x |
| Cash | €84.70m |
| Equity | €527.90m |
| Total liabilities | €918.90m |
| Total assets | €1.45b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIES.F's short term assets (€796.2M) exceed its short term liabilities (€391.2M).
Long Term Liabilities: BIES.F's short term assets (€796.2M) exceed its long term liabilities (€527.7M).
Debt to Equity History and Analysis
Debt Level: BIES.F's net debt to equity ratio (115.3%) is considered high.
Reducing Debt: BIES.F's debt to equity ratio has increased from 71.4% to 131.3% over the past 5 years.
Debt Coverage: BIES.F's debt is not well covered by operating cash flow (3.3%).
Interest Coverage: BIES.F's interest payments on its debt are well covered by EBIT (5x coverage).